United States

Showing 251-260 of 328 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
JDRF T1D Coordinating Center	Jaeb Center for Health Research	Judy Sibayan	Transportfolio	01-August-2019 to 31-August-2027	$2,914,531.01
Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes	iTolerance, Inc.	Camillo Ricordi	Cures	01-June-2022 to 31-August-2025	$850,000.00
Adult T1D Detection at Geisinger	IQVIA, Inc.	Nadejda Leavitt	Cures	01-July-2023 to 31-December-2025	$890,727.00
Advancing T1D Detection and Care Through AI	IQVIA, Inc.	Nadejda Leavitt	Cures	01-February-2025 to 31-January-2026	$345,083.00
JDRF-IQVIA Adult T1D Detection	IQVIA, Inc.	Nadejda Leavitt	Cures	01-October-2022 to 31-August-2025	$953,780.00
A smart Semiconductor based Continuous Diabetes Monitoring Platform	Integrated Medical Sensors Inc	Muhammad Mujeeb-U-Rahman	Improving Lives	01-June-2022 to 31-May-2025	$500,000.00
ROLE OF ZBED3 IN BETA CELL STRESS RESPONSE AND VULNERABILITY AGAINST AUTOIMMUNITY	Indiana Biosciences Research Institute	Erica Cai	Cures	01-March-2023 to 29-February-2028	$999,737.71
Targeting ER cargo proteins for beta cell protection against cellular stress and autoimmunity	Indiana Biosciences Research Institute	Erica Cai	Cures	01-September-2023 to 31-August-2026	$499,934.12
Genome-scale CRISPR screens identify ER export cargo proteins as mediators for β-cell stress response and antigen presentation	Indiana Biosciences Research Institute	Isabela Lovizutto Iessi Longo	Cures	01-March-2023 to 28-February-2026	$135,307.11
Exploiting SDF2L1 to protect against beta cell death and dysfunction in T1D	Indiana Biosciences Research Institute	Michael Kalwat	Cures	01-December-2024 to 30-November-2027	$748,169.00